MicroPort Scientific (HKSE:00853) LT-Debt-to-Total-Asset : 0.23 (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is MicroPort Scientific LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. MicroPort Scientific's long-term debt to total assests ratio for the quarter that ended in Dec. 2023 was 0.23.

MicroPort Scientific's long-term debt to total assets ratio declined from Dec. 2022 (0.31) to Dec. 2023 (0.23). It may suggest that MicroPort Scientific is progressively becoming less dependent on debt to grow their business.

MicroPort Scientific LT-Debt-to-Total-Asset Historical Data

The historical data trend for MicroPort Scientific's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort Scientific LT-Debt-to-Total-Asset Chart

MicroPort Scientific Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.21

0.11

0.25

0.31

0.23

MicroPort Scientific Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.25	0.28	0.31	0.16	0.23

MicroPort Scientific LT-Debt-to-Total-Asset Calculation

MicroPort Scientific's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	7026.946	/	30711.297
	=	0.23

MicroPort Scientific's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (Q: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2023 )	/	Total Assets (Q: Dec. 2023 )
	=	7026.946	/	30711.297
	=	0.23

MicroPort Scientific (HKSE:00853) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

MicroPort Scientific LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of MicroPort Scientific's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

MicroPort Scientific (HKSE:00853) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort Scientific Corp (HKSE:00853) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

MCRPF:USA MSK:Germany

Address

1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Shanghai, CHN, 201203

Website

https://www.microport.com

MicroPort Scientific Corp develops & markets medical devices in eight segments. Cardiovascular devices business: sales, manufacture, R&D of cardiovascular devices like drug-eluting stents. Orthopedics devices business: sales, manufacture, R&D of orthopedics devices. CRM business: sales, manufacture, R&D of cardiac rhythm management devices. Endovascular & peripheral vascular devices business: sales, manufacture, R&D of endovascular & peripheral vascular devices. Neurovascular devices business: sales, manufacture, R&D of neurovascular devices. Heart valve business: sales, manufacture, R&D of heart valve devices. Surgical robot business: sales, manufacture, R&D of surgical robot devices. Surgical devices business: sales, manufacture, R&D of surgical devices. The key revenue is from The PRC.

Executives

Shang Hai Zhang Jiang Ji Tuan You Xian Gong Si	2201 Interest of corporation controlled by you
Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Maxwell Maxcare Science Foundation Limited	2201 Interest of corporation controlled by you
We'tron Capital Limited	2101 Beneficial owner
Hillhouse Investment Management, Ltd.	2102 Investment manager
Hfty I Holdings Pte. Ltd.	2101 Beneficial owner
Otsuka Holdings Co., Ltd.
Otsuka Medical Devices Co., Ltd.
Hillhouse Capital Advisors, Ltd.	2102 Investment manager
Gaoling Fund, L.p.	2101 Beneficial owner

MicroPort Scientific (HKSE:00853) Headlines

No Headlines